Mali, P., & Labban, M. (2023). HPR116 US List Prices for Maine'S High-Cost Highly Prescribed Drugs Were over 7-Fold Higher Than the Lowest Canadian Prices. Value in Health, 26(6), S231. https://doi.org/10.1016/j.jval.2023.03.1263
Chicago Style (17th ed.) CitationMali, P.K, and M. Labban. "HPR116 US List Prices for Maine'S High-Cost Highly Prescribed Drugs Were over 7-Fold Higher Than the Lowest Canadian Prices." Value in Health 26, no. 6 (2023): S231. https://doi.org/10.1016/j.jval.2023.03.1263.
MLA (9th ed.) CitationMali, P.K, and M. Labban. "HPR116 US List Prices for Maine'S High-Cost Highly Prescribed Drugs Were over 7-Fold Higher Than the Lowest Canadian Prices." Value in Health, vol. 26, no. 6, 2023, p. S231, https://doi.org/10.1016/j.jval.2023.03.1263.